The aggressiveness level of ovarian tumor is of great importance for clinical treatment and prognosis. The purpose of this study is to explore the value of R2 * in evaluating the aggressiveness of ovarian tumors. The preliminary results showed that the R2 * value of malignant tumors was significantly higher than benign and borderline tumors. R2* is potentially a promising and valuable non-invasive method in evaluating the aggressiveness of ovarian tumors.
This abstract and the presentation materials are available to members only; a login is required.